Independent Advisor Alliance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.56M Buy
91,748
+10,313
+13% +$601K 0.06% 292
2025
Q4
$4.39M Sell
81,435
-6,200
-7% -$298K 0.11% 154
2025
Q3
$3.95M Buy
87,635
+13,950
+19% +$651K 0.1% 174
2025
Q2
$3.41M Sell
73,685
-2,388
-3% -$117K 0.1% 180
2025
Q1
$4.64M Buy
76,073
+5,024
+7% +$293K 0.15% 113
2024
Q4
$4.02M Buy
71,049
+25,330
+55% +$1.42M 0.05% 322
2024
Q3
$2.37M Buy
45,719
+1,654
+4% +$77.6K 0.09% 195
2024
Q2
$1.83M Sell
44,065
-2,876
-6% -$129K 0.06% 235
2024
Q1
$2.55M Buy
46,941
+14,596
+45% +$744K 0.09% 185
2023
Q4
$1.66M Sell
32,345
-3,595
-10% -$189K 0.06% 234
2023
Q3
$2.09M Sell
35,940
-3,670
-9% -$225K 0.09% 190
2023
Q2
$2.53M Sell
39,610
-284
-0.7% -$19K 0.11% 167
2023
Q1
$2.77M Sell
39,894
-4,786
-11% -$338K 0.13% 142
2022
Q4
$3.21K Sell
44,680
-107
-0.2% -$8.07K ﹤0.01% 210
2022
Q3
$3.18M Buy
44,787
+437
+1% +$31.7K 0.19% 112
2022
Q2
$3.42M Sell
44,350
-659
-1% -$50.2K 0.19% 108
2022
Q1
$3.29M Buy
45,009
+6,756
+18% +$454K 0.16% 124
2021
Q4
$2.38M Buy
38,253
+1,256
+3% +$73.7K 0.12% 142
2021
Q3
$2.19M Buy
36,997
+752
+2% +$49.5K 0.12% 147
2021
Q2
$2.42M Sell
36,245
-554
-2% -$36.1K 0.13% 151
2021
Q1
$2.32M Sell
36,799
-1,642
-4% -$102K 0.14% 140
2020
Q4
$2.38M Buy
38,441
+1,352
+4% +$83.1K 0.16% 122
2020
Q3
$2.24M Sell
37,089
-1,798
-5% -$108K 0.17% 117
2020
Q2
$2.29M Buy
38,887
+4,424
+13% +$265K 0.24% 87
2020
Q1
$1.92M Sell
34,463
-14,031
-29% -$858K 0.28% 70
2019
Q4
$3.11M Buy
48,494
+11,281
+30% +$646K 0.14% 165
2019
Q3
$1.92M Sell
37,213
-444
-1% -$20.9K 0.24% 98
2019
Q2
$1.48M Buy
37,657
+11,000
+41% +$512K 0.21% 96
2019
Q1
$1.27M Buy
26,657
+2,514
+10% +$125K 0.18% 117
2018
Q4
$1.25M Buy
24,143
+533
+2% +$28.6K 0.22% 99
2018
Q3
$1.43M Buy
23,610
+997
+4% +$59.2K 0.26% 91
2018
Q2
$1.22M Sell
22,613
-21
-0.1% -$1.13K 0.25% 95
2018
Q1
$1.4M Sell
22,634
-770
-3% -$49.5K 0.31% 83
2017
Q4
$1.45M Buy
23,404
+3,526
+18% +$221K 0.32% 83
2017
Q3
$1.27M Sell
19,878
-838
-4% -$48.9K 0.35% 78
2017
Q2
$1.16M Sell
20,716
-3,487
-14% -$190K 0.37% 80
2017
Q1
$1.28M Buy
24,203
+3,399
+16% +$186K 0.2% 136
2016
Q4
$1.02M Buy
+20,804
New +$1.14M 0.44% 71

Other funds holding BMY

Independent Advisor Alliance's BMY Position: Q1 2026 in Review

Independent Advisor Alliance increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $601K and bringing the position to 91,748 shares worth $5.56M. The position accounts for 0.06% of the portfolio, ranked #292.

Independent Advisor Alliance first reported a position in BMY in Q4 2016 and has held it in 38 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Independent Advisor Alliance held 91,748 shares of Bristol-Myers Squibb worth $5.56M as of Q1 2026.
  • Independent Advisor Alliance bought 10,313 Bristol-Myers Squibb shares in Q1 2026, an estimated $601K.
  • Bristol-Myers Squibb made up 0.06% of Independent Advisor Alliance's portfolio in Q1 2026, its #292 holding.
  • Independent Advisor Alliance first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 38 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.